Sexual Dimorphism in Cardiometabolic Diseases: From Development to Senescence and Therapeutic Approaches
Cells · 2025
DOI: 10.3390/cells14060467 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, 2025. Verfasst von Thea Chevalley und 7 weiteren Autor:innen. Beteiligte Einrichtung: Developmental Origins of Health and Disease (DOHaD) Laboratory, Division of Pediatrics, Department Woman-Mother-Child, Lausanne University Hospital, …. Hauptthemen laut MEDLINE: Sex Characteristics, Cardiovascular Diseases, Metabolic Diseases, Aging. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 573 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swiss Heart Foundation.
Abstract (Originalsprache)
The global incidence and prevalence of cardiometabolic disorders have risen significantly in recent years. Although lifestyle choices in adulthood play a crucial role in the development of these conditions, it is well established that events occurring early in life can have an important effect. Recent research on cardiometabolic diseases has highlighted the influence of sexual dimorphism on risk factors, underlying mechanisms, and response to therapies. In this narrative review, we summarize the current understanding of sexual dimorphism in cardiovascular and metabolic diseases in the general population and within the framework of the Developmental Origins of Health and Disease (DOHaD) concept. We explore key risk factors and mechanisms, including the influence of genetic and epigenetic factors, placental and embryonic development, maternal nutrition, sex hormones, energy metabolism, microbiota, oxidative stress, cell death, inflammation, endothelial dysfunction, circadian rhythm, and lifestyle factors. Finally, we discuss some of the main therapeutic approaches, responses to which may be influenced by sexual dimorphism, such as antihypertensive and cardiovascular treatments, oxidative stress management, nutrition, cell therapies, and hormone replacement therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Developmental Origins of Health and Disease (DOHaD) Laboratory, Division of Pediatrics, Department Woman-Mother-Child, Lausanne University Hospital, University of Lausanne, 1011 Lausanne, Switzerland.
ORCID-Profile: Thea Chevalley, Laurent Fumeaux, Alexandre Sarre, Umberto Simeoni, Catherine Yzydorczyk
Förderung
- Swiss Heart Foundation
Zitieren
APA
Chevalley, T., Dübi, M., Fumeaux, L., Merli, M. S., Sarre, A., Schaer, N., Simeoni, U., & Yzydorczyk, C. (2025). Sexual Dimorphism in Cardiometabolic Diseases: From Development to Senescence and Therapeutic Approaches. Cells. https://doi.org/10.3390/cells14060467
Vancouver
Chevalley T, Dübi M, Fumeaux L, Merli MS, Sarre A, Schaer N, et al. Sexual Dimorphism in Cardiometabolic Diseases: From Development to Senescence and Therapeutic Approaches. Cells. 2025. doi:10.3390/cells14060467
BibTeX
@article{Chevalley2025,
author = {Chevalley, Thea and Dübi, Marion and Fumeaux, Laurent and Merli, Maria Serena and Sarre, Alexandre and Schaer, Natacha and Simeoni, Umberto and Yzydorczyk, Catherine},
title = {Sexual Dimorphism in Cardiometabolic Diseases: From Development to Senescence and Therapeutic Approaches},
journal = {Cells},
year = {2025},
doi = {10.3390/cells14060467}
}
EUVIMED